Xenetic Biosciences, Inc. (XBIO)
1.72
-0.21
(-10.88%)
USD |
NASDAQ |
Oct 23, 16:00
1.71
-0.01
(-0.58%)
After-Hours: 20:00
Xenetic Biosciences Price : 1.72 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.90 | 1.900 | 1.72 | 1.72 | 22122.00 |
| Oct 22, 2026 | 2.03 | 2.04 | 1.90 | 1.93 | 18880.00 |
| Oct 21, 2026 | 2.00 | 2.03 | 1.97 | 2.02 | 6830.00 |
| Oct 20, 2026 | 1.96 | 2.05 | 1.96 | 2.00 | 11488.00 |
| Oct 19, 2026 | 1.93 | 1.95 | 1.85 | 1.93 | 10122.00 |
| Oct 16, 2026 | 1.98 | 2.00 | 1.92 | 1.99 | 17529.00 |
| Oct 15, 2026 | 2.09 | 2.10 | 1.885 | 2.01 | 51379.00 |
| Oct 14, 2026 | 2.07 | 2.14 | 2.07 | 2.10 | 12575.00 |
| Oct 13, 2026 | 2.14 | 2.175 | 2.040 | 2.10 | 35744.00 |
| Oct 12, 2026 | 2.14 | 2.27 | 2.11 | 2.12 | 8503.00 |
| Oct 09, 2026 | 2.195 | 2.231 | 2.13 | 2.13 | 10232.00 |
| Oct 08, 2026 | 2.18 | 2.18 | 2.10 | 2.12 | 13553.00 |
| Oct 07, 2026 | 2.11 | 2.21 | 2.11 | 2.21 | 15557.00 |
| Oct 06, 2026 | 2.19 | 2.340 | 2.100 | 2.12 | 14726.00 |
| Oct 05, 2026 | 2.23 | 2.29 | 2.19 | 2.20 | 9529.00 |
| Oct 02, 2026 | 2.30 | 2.33 | 2.110 | 2.24 | 43296.00 |
| Oct 01, 2026 | 2.335 | 2.335 | 2.21 | 2.24 | 13384.00 |
| Sep 30, 2026 | 2.26 | 2.335 | 2.22 | 2.32 | 33480.00 |
| Sep 29, 2026 | 2.34 | 2.35 | 2.25 | 2.26 | 12351.00 |
| Sep 28, 2026 | 2.37 | 2.475 | 2.23 | 2.33 | 34799.00 |
| Sep 25, 2026 | 2.42 | 2.530 | 2.330 | 2.39 | 50718.00 |
| Sep 24, 2026 | 2.56 | 2.56 | 2.28 | 2.47 | 64032.00 |
| Sep 23, 2026 | 2.65 | 2.65 | 2.43 | 2.52 | 91401.00 |
| Sep 22, 2026 | 2.99 | 2.99 | 2.436 | 2.57 | 155124.0 |
| Sep 21, 2026 | 2.81 | 3.10 | 2.80 | 2.99 | 145784.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 58.02 |
| Oncolytics Biotech, Inc. | 0.5023 |
| Sangamo Therapeutics, Inc. | 0.115 |
| Sarepta Therapeutics, Inc. | 17.73 |
| Anixa Biosciences, Inc. | 2.99 |
Price Related Metrics
| PS Ratio | 1.110 |
| Price to Book Value | 0.6636 |
| Earnings Yield | -69.06% |
| Market Cap | 4.030M |